189 related articles for article (PubMed ID: 26761771)
1. Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.
Schweitzer M; Makhoul S; Paliouras M; Beitel LK; Gottlieb B; Trifiro M; Chowdhury SF; Zaman NM; Wang E; Davis H; Chalifour LE
Atherosclerosis; 2016 Mar; 246():78-86. PubMed ID: 26761771
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
[TBL] [Abstract][Full Text] [Related]
3. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
Davis HR; Veltri EP
J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
[TBL] [Abstract][Full Text] [Related]
4. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease.
Lauridsen BK; Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2015 Jul; 36(25):1601-8. PubMed ID: 25841872
[TBL] [Abstract][Full Text] [Related]
6. Extracellular loop C of NPC1L1 is important for binding to ezetimibe.
Weinglass AB; Kohler M; Schulte U; Liu J; Nketiah EO; Thomas A; Schmalhofer W; Williams B; Bildl W; McMasters DR; Dai K; Beers L; McCann ME; Kaczorowski GJ; Garcia ML
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11140-5. PubMed ID: 18682566
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.
Kashiwabara Y; Kobayashi Y; Koba S; Kohyama N; Ohbayashi M; Murayama JI; Hirano T; Kobayashi Y; Yamamoto T
J Clin Pharm Ther; 2014 Oct; 39(5):551-4. PubMed ID: 24861377
[TBL] [Abstract][Full Text] [Related]
8. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
[TBL] [Abstract][Full Text] [Related]
9. The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.
Zsíros N; Bodor M; Varga V; Berta E; Balogh I; Seres I; Paragh G; Harangi M
Pharmazie; 2014 Jun; 69(6):424-9. PubMed ID: 24974575
[TBL] [Abstract][Full Text] [Related]
10. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe.
Wang J; Williams CM; Hegele RA
Clin Genet; 2005 Feb; 67(2):175-7. PubMed ID: 15679830
[TBL] [Abstract][Full Text] [Related]
12. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
Simon JS; Karnoub MC; Devlin DJ; Arreaza MG; Qiu P; Monks SA; Severino ME; Deutsch P; Palmisano J; Sachs AB; Bayne ML; Plump AS; Schadt EE
Genomics; 2005 Dec; 86(6):648-56. PubMed ID: 16297596
[TBL] [Abstract][Full Text] [Related]
13. Fomiroid A, a novel compound from the mushroom Fomitopsis nigra, inhibits NPC1L1-mediated cholesterol uptake via a mode of action distinct from that of ezetimibe.
Chiba T; Sakurada T; Watanabe R; Yamaguchi K; Kimura Y; Kioka N; Kawagishi H; Matsuo M; Ueda K
PLoS One; 2014; 9(12):e116162. PubMed ID: 25551765
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.
Temel RE; Tang W; Ma Y; Rudel LL; Willingham MC; Ioannou YA; Davies JP; Nilsson LM; Yu L
J Clin Invest; 2007 Jul; 117(7):1968-78. PubMed ID: 17571164
[TBL] [Abstract][Full Text] [Related]
15. N-terminal domain of the cholesterol transporter Niemann-Pick C1-like 1 (NPC1L1) is essential for α-tocopherol transport.
Kamishikiryo J; Haraguchi M; Nakashima S; Tasaka Y; Narahara H; Sugihara N; Nakamura T; Morita T
Biochem Biophys Res Commun; 2017 Apr; 486(2):476-480. PubMed ID: 28315682
[TBL] [Abstract][Full Text] [Related]
16. NPC1L1: evolution from pharmacological target to physiological sterol transporter.
Huff MW; Pollex RL; Hegele RA
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2433-8. PubMed ID: 16973966
[TBL] [Abstract][Full Text] [Related]
17. Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
Narushima K; Takada T; Yamanashi Y; Suzuki H
Mol Pharmacol; 2008 Jul; 74(1):42-9. PubMed ID: 18403720
[TBL] [Abstract][Full Text] [Related]
18. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).
Garcia-Calvo M; Lisnock J; Bull HG; Hawes BE; Burnett DA; Braun MP; Crona JH; Davis HR; Dean DC; Detmers PA; Graziano MP; Hughes M; Macintyre DE; Ogawa A; O'neill KA; Iyer SP; Shevell DE; Smith MM; Tang YS; Makarewicz AM; Ujjainwalla F; Altmann SW; Chapman KT; Thornberry NA
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8132-7. PubMed ID: 15928087
[TBL] [Abstract][Full Text] [Related]
19. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
20. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
